This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend the Oncology Professional Care Show

If you would like more information on oncology, please refer to the NHS website.

Visit the NHS website?

Sidebar CTAs

Understanding Cardio-oncology and Potential Impacts on Patients

Loading

Understanding Cardio-oncology and Potential Impacts on Patients

24 May 2022
Clinical Excellence in Surgery and Therapeutics
Understanding Cardio-oncology and Potential Impacts on Patients
Cardio-oncology is a new multidisciplinary field that involves the management of cardiovascular side effects in patients receiving anti-cancer therapies . Recent advances in clinical oncology resulted in an increased number of anti-cancer drugs that have a direct effect on the heart. Early diagnosis, prevention, risk stratification, early treatment and serial monitoring are the major principles of cardio-oncology. Although some patients experience cardiotoxicity secondary to anti-cancer treatment, the rest complete their treatment without any alteration in cardiac functions. Risk factors may have an effect on developing cardiotoxicity in patients receiving cardiotoxic anti-cancer drugs. Optimal management of cardio-oncology patients should be based on inter-professional collaboration.
Speakers
Hasan Kobat, PhD researcher in Cardio-Oncology - Kingston University London
Carl Booth, Consultant Pharmacist for Cancer Services and Head of the Chemotherapy Service - Airedale NHS
Shereen Nabhani-Gebara, Associate Professor of Oncology Kingston University London - Chair of the research committee at the British Oncology Pharmacy Association